Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 22, 2024
A landscape review to identify what matters to patients with thrombotic cardiovascular diseases and patient-reported outcome instruments which can be used to capture the patient experience
Alexandra I Barsdorf, John Fastenau, Shannon Lee, et al.
BMC Psychiatry
|
September 11, 2013
Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
Marie-Hélène Lafeuille, François Laliberté-Auger, Patrick Lefebvre, et al.
Journal of Comparative Effectiveness Research
|
July 15, 2015
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
Yongling Xiao, Erik Muser, Marie-Hélène Lafeuille, et al.
Journal of Medical Economics
|
September 7, 2013
Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics
Marie-Hélène Lafeuille, Jonathan Gravel, Patrick Lefebvre, et al.
Current Medical Research and Opinion
|
April 16, 2014
Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
The Clinical Respiratory Journal
|
December 25, 2025
Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States
Maitreyee Mohanty, Fei Tang, John Fastenau, et al.
The American Journal of Managed Care
|
June 9, 2016
Medicaid managed care penetration and drug utilization for patients with serious mental illness
Aaron L Schwartz, Jacqueline Pesa, Dilesh Doshi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 6, 2014
Burden of schizophrenia on selected comorbidity costs
Marie-Hélène Lafeuille, Jason Dean, John Fastenau, et al.
American Health & Drug Benefits
|
December 21, 2016
Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia
Marie-Hélène Lafeuille, Christian Frois, Michel Cloutier, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 22, 2024
A landscape review to identify what matters to patients with thrombotic cardiovascular diseases and patient-reported outcome instruments which can be used to capture the patient experience
Alexandra I Barsdorf, John Fastenau, Shannon Lee, et al.
BMC Psychiatry
|
September 11, 2013
Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
Marie-Hélène Lafeuille, François Laliberté-Auger, Patrick Lefebvre, et al.
Journal of Comparative Effectiveness Research
|
July 15, 2015
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
Yongling Xiao, Erik Muser, Marie-Hélène Lafeuille, et al.
Journal of Medical Economics
|
September 7, 2013
Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics
Marie-Hélène Lafeuille, Jonathan Gravel, Patrick Lefebvre, et al.
Current Medical Research and Opinion
|
April 16, 2014
Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
The Clinical Respiratory Journal
|
December 25, 2025
Impact of Bronchiectasis on Healthcare Resource Utilization and Direct Medical Costs of Managing Comorbid Chronic Obstructive Pulmonary Disease, Asthma, and Rheumatoid Arthritis in the United States
Maitreyee Mohanty, Fei Tang, John Fastenau, et al.
The American Journal of Managed Care
|
June 9, 2016
Medicaid managed care penetration and drug utilization for patients with serious mental illness
Aaron L Schwartz, Jacqueline Pesa, Dilesh Doshi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 6, 2014
Burden of schizophrenia on selected comorbidity costs
Marie-Hélène Lafeuille, Jason Dean, John Fastenau, et al.
American Health & Drug Benefits
|
December 21, 2016
Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia
Marie-Hélène Lafeuille, Christian Frois, Michel Cloutier, et al.
Page
of 5